Polymerase chain reaction (PCR) testing lab HealthTrackRx has retained Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) to perform the Molecular Laboratory Developed (LDT) COVID-19 Authorized Test.

The lab is one of 27 labs nationwide permitted to use the LDT COVID-19 Test under the FDA EUA.

“Since the beginning of the pandemic, HealthTrackRx has made significant strides to make testing more accurate and accessible. We know that testing is a critical tool for combating COVID-19, and we will continue to provide our clients with fast, accurate testing under the EUA,” says Martin Price, executive chairman of HealthTrackRx.

EUA authority is exercised by the FDA to protect public health and safety against COVID-19 by facilitating the availability and use of “medical countermeasures” (MCMs).

HealthTrackRx real-time PCR COVID-19 test is used to accurately detect pathogens on the molecular level. The technology offers considerably faster results when compared to culture testing. Providers receive COVID-19 test results in 24 hours or less.